Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Preparation and controlled-release studies of a protocatechuic acid-magnesium/aluminum-layered double hydroxide nanocomposite.

Barahuie F, Hussein MZ, Hussein-Al-Ali SH, Arulselvan P, Fakurazi S, Zainal Z.

Int J Nanomedicine. 2013;8:1975-87. doi: 10.2147/IJN.S42718. Epub 2013 May 20.

2.

Anticancer nanodelivery system with controlled release property based on protocatechuate-zinc layered hydroxide nanohybrid.

Barahuie F, Hussein MZ, Abd Gani S, Fakurazi S, Zainal Z.

Int J Nanomedicine. 2014 Jun 26;9:3137-49. doi: 10.2147/IJN.S59541. eCollection 2014.

3.
4.

Antituberculosis nanodelivery system with controlled-release properties based on para-amino salicylate-zinc aluminum-layered double-hydroxide nanocomposites.

Saifullah B, Hussein MZ, Hussein-Al-Ali SH, Arulselvan P, Fakurazi S.

Drug Des Devel Ther. 2013 Nov 13;7:1365-75. doi: 10.2147/DDDT.S50665. eCollection 2013.

5.

Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent.

Kura AU, Hussein Al Ali SH, Hussein MZ, Fakurazi S, Arulselvan P.

Int J Nanomedicine. 2013;8:1103-10. doi: 10.2147/IJN.S39740. Epub 2013 Mar 16.

6.

Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite.

Hussein Al Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN.

Int J Nanomedicine. 2012;7:2129-41. doi: 10.2147/IJN.S30461. Epub 2012 Apr 24.

7.

Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells.

Hasan S, Al Ali H, Al-Qubaisi M, Zobir Hussein M, Ismail M, Zainal Z, Nazrul Hakim M.

Int J Nanomedicine. 2012;7:3351-63. doi: 10.2147/IJN.S30809. Epub 2012 Jul 3.

8.

In vitro controlled release of vitamin C from Ca/Al layered double hydroxide drug delivery system.

Gao X, Chen L, Xie J, Yin Y, Chang T, Duan Y, Jiang N.

Mater Sci Eng C Mater Biol Appl. 2014 Jun 1;39:56-60. doi: 10.1016/j.msec.2014.02.028. Epub 2014 Feb 22.

PMID:
24863197
9.

Mg-Al layered double hydroxide-methotrexate nanohybrid drug delivery system: evaluation of efficacy.

Chakraborty J, Roychowdhury S, Sengupta S, Ghosh S.

Mater Sci Eng C Mater Biol Appl. 2013 May 1;33(4):2168-74. doi: 10.1016/j.msec.2013.01.047. Epub 2013 Jan 28.

PMID:
23498245
10.

In vitro inhibition of histamine release behavior of cetirizine intercalated into Zn/Al- and Mg/Al-layered double hydroxides.

Hussein-Al-Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN.

Int J Mol Sci. 2012;13(5):5899-916. doi: 10.3390/ijms13055899. Epub 2012 May 16.

11.

The in vitro sustained release profile and antitumor effect of etoposide-layered double hydroxide nanohybrids.

Qin L, Wang M, Zhu R, You S, Zhou P, Wang S.

Int J Nanomedicine. 2013;8:2053-64. doi: 10.2147/IJN.S43203. Epub 2013 May 24.

12.

Comparative study of Mg/Al- and Zn/Al-layered double hydroxide-perindopril erbumine nanocomposites for inhibition of angiotensin-converting enzyme.

Hussein Al Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN.

Int J Nanomedicine. 2012;7:4251-62. doi: 10.2147/IJN.S32267. Epub 2012 Aug 3.

13.

Synthesis of composites of sodium oleate/Mg-Al-ascorbic acid-layered double hydroxides for drug delivery applications.

Kameshima Y, Sasaki H, Isobe T, Nakajima A, Okada K.

Int J Pharm. 2009 Oct 20;381(1):34-9. doi: 10.1016/j.ijpharm.2009.07.021. Epub 2009 Jul 29.

PMID:
19646517
14.

Preparation of Tween 80-Zn/Al-levodopa-layered double hydroxides nanocomposite for drug delivery system.

Kura AU, Hussein-Al-Ali SH, Hussein MZ, Fakurazi S.

ScientificWorldJournal. 2014 Mar 23;2014:104246. doi: 10.1155/2014/104246. eCollection 2014.

15.

Optimization of UV absorptivity of layered double hydroxide by intercalating organic UV-absorbent molecules.

Mohsin SM, Hussein MZ, Sarijo SH, Fakurazi S, Arulselvan P, Taufiq-Yap YH.

J Biomed Nanotechnol. 2014 Aug;10(8):1490-500.

PMID:
25016649
16.
17.

Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system.

Barahuie F, Dorniani D, Saifullah B, Gothai S, Hussein MZ, Pandurangan AK, Arulselvan P, Norhaizan ME.

Int J Nanomedicine. 2017 Mar 27;12:2361-2372. doi: 10.2147/IJN.S126245. eCollection 2017.

18.

Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.

Barahuie F, Saifullah B, Dorniani D, Fakurazi S, Karthivashan G, Hussein MZ, Elfghi FM.

Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:177-185. doi: 10.1016/j.msec.2016.11.114. Epub 2016 Dec 5.

PMID:
28254283
19.

Controlled release of a plant growth regulator, alpha-naphthaleneacetate from the lamella of Zn-Al-layered double hydroxide nanocomposite.

bin Hussein MZ, Zainal Z, Yahaya AH, Foo DW.

J Control Release. 2002 Aug 21;82(2-3):417-27.

PMID:
12175754
20.

Preparation and optimization of a drug delivery system based on berberine chloride-immobilized MgAl hydrotalcite.

Djebbi MA, Bouaziz Z, Elabed A, Sadiki M, Elabed S, Namour P, Jaffrezic-Renault N, Amara AB.

Int J Pharm. 2016 Jun 15;506(1-2):438-48. doi: 10.1016/j.ijpharm.2016.04.048. Epub 2016 Apr 21.

PMID:
27109050

Supplemental Content

Support Center